According to Cutting Edge Information, Prospect of Innovative Treatment Tops List of Patient Incentives
RESEARCH TRIANGLE PARK, NC--(Marketwire - November 12, 2008) - Pharmaceutical companies are
finding that more than any other enticement for recruiting patients for a
clinical study, the prospect of innovative treatment is the most appealing,
according to "Streamlining Clinical Trials," a new study by pharmaceutical
business intelligence leader Cutting Edge Information. The prospect of
receiving a free treatment was the second most attractive reason for
patients to join a clinical trial.
Pharmaceutical companies are constantly looking for new ways to stimulate
growth and retention of patient prospects for clinical trials. The
prospects of free and innovative treatments were by far the most effective
methods for pharmaceutical companies to gather the necessary number of
participants to a trial.
Other ways in which pharmaceutical companies are collecting an ample number
of patients is through physician visits, shortened trials, and monetary
compensation. One of the factors that companies wrestle with is the
balance of appropriate incentives while maintaining the efficacy of the
trial.
"It is encouraging for the pharmaceutical industry to find patients so
eager to receive innovative treatment," says lead author of the report
David Richardson. "Ideally, this mindset will translate into new and
improved methods for treating indications."
"Streamlining Clinical Trials" (www.clinicaltrialbenchmarking.com) covers
resource allocation, performance measurement, continuous process
improvement, patient and investigator recruitment and adaptive trial
designs. Data include clinical development budgets, clinical operations
team structures and staffing levels, performance measurement and
management, clinical operations hurdles and process improvement tools and
tactics. The report focuses on three aspects:
Patient Recruitment: Patient recruitment continues to dominate clinical
timelines and budgets. The report devotes an entire chapter to this
challenge, providing the latest trends and tools in recruitment.
Budgeting and Performance Assessments: Clinical project managers must set
clear performance expectations and measure and manage trials. The report
provides clinical spending benchmarks to assist in trial budgeting and
planning.
Clinical Operations Structure and Work Flow: Clinical trial management team
members must know their roles and responsibilities, and communication with
vendors and investigators must be seamless. The report outlines major
obstacles clinical teams face and presents real-company, proven solutions.
Contact Information: CONTACT INFORMATION:
David Richardson
919-433-0216